QQ客服 官方微博 反馈留言

	Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite
	Wei-Siang Liao; Yu Ho; Yu-Wei Lin; Emmanuel Naveen Raj; Kuang-Kai Liu; Chinpiao Chen; Xiao-Zhen Zhou; Kun-Ping Lu; Jui-I Chao
刊名	Acta Biomaterialia
	2019
卷号	Vol.86页码:395-405
关键词	Cetuximab EGFR Paclitaxel Nanodiamond Triple-negative breast cancer
ISSN号	1742-7061
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4737886
专题	湖南大学
作者单位	1.d Division of Translational Therapeutics, Department of Medicine and the Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, CLS 0408 Boston, MA, USA 2.Institute of Molecular Medicine and Bioengineering, National Chiao Tung University, Hsinchu 30068, Taiwan 3.Department of Chemistry, National Dong Hwa University, Hualien 97401, Taiwan 4.Center For Intelligent Drug Systems and Smart Bio-devices, National Chiao Tung University, Hsinchu 30068, Taiwan a Department and Institute of Biological Science and Technology, National Chiao Tung University, Hsinchu 30068, Taiwan
推荐引用方式 GB/T 7714	Wei-Siang Liao,Yu Ho,Yu-Wei Lin,et al. Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite[J]. Acta Biomaterialia,2019,Vol.86:395-405.
APA	Wei-Siang Liao.,Yu Ho.,Yu-Wei Lin.,Emmanuel Naveen Raj.,Kuang-Kai Liu.,...&Jui-I Chao.(2019).Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite.Acta Biomaterialia,Vol.86,395-405.
MLA	Wei-Siang Liao,et al."Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite".Acta Biomaterialia Vol.86(2019):395-405.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。